TY - JOUR T1 - Age and Comorbidities Influence Initial Treatment of Patients with Early Rheumatoid Arthritis JF - The Journal of Rheumatology JO - J Rheumatol SP - 827 LP - 828 DO - 10.3899/jrheum.150828 VL - 43 IS - 4 AU - DAVID VEGA-MORALES AU - DANIEL TREVIÑO-MONTES AU - MARTIN WAH-SUAREZ Y1 - 2016/04/01 UR - http://www.jrheum.org/content/43/4/827.abstract N2 - To the Editor:We are quite interested in the study recently published by Dr. Helga Radner, et al1, in which they compared treatment profiles between multimorbid established rheumatoid arthritis (RA) patients and patients with RA only. They found a decrease in biologic disease-modifying antirheumatic drugs used for each additional chronic comorbidity1. We, too, have observed the influence of comorbidities on decision making in the initial treatment of patients with early RA. The aim of our study was to evaluate such influences. Our retrospective and observational study was done between March 2014 and March 2015. We included all medical records of patients with RA according to 2010 American College … Address correspondence to Dr. D. Vega-Morales, Hospital Universitario, Rheumatology, Francisco I. Madero S/N, Mitras Centro, Monterrey, Mexico. E-mail: drdavidvega{at}yahoo.com.mx ER -